Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|January 23, 2023
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS diseaseChristina Fong, Brian H Kushner, Angela Di Giannatale, et al.Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.Journal of Pediatric Surgery|December 15, 2015
Salvage rates after progression of high-risk neuroblastoma with a soft tissue massJennifer M Murphy, Irene-Isabel P Lim, Benjamin A Farber, et al.International Journal of Cancer|March 26, 2018
Treatment and outcome of adult-onset neuroblastomaMaya Suzuki, Brian H Kushner, Kim Kramer, et al.Oncotarget|December 10, 2017
MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapyBrian H Kushner, Michael P LaQuaglia, Shakeel Modak, et al.Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|March 8, 2021
Stepwise Strategic Mitigation Planning in a Pediatric Oncology Center During the COVID-19 PandemicVictoria Szenes, Rachel Bright, Deborah Diotallevi, et al.International Journal of Cancer|August 21, 2023
Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapyBrian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, et al.Molecular Cancer Therapeutics|September 5, 2021
Translational Strategies for Repotrectinib in NeuroblastomaTara J O'Donohue, Glorymar Ibáñez, Diego Ferreira Coutinho, et al.Oncoimmunology|September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I studyShakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
GABAergic system gene expression predicts clinical outcome in patients with neuroblastomaStephen S Roberts, Motomi Mori, Patrick Pattee, et al.Pageof 6